Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 7Plasma cell 3Other solid neoplasm 2Other hematologic neoplasm 2Tumor-Agnostic 1Sarcoma 1Myeloid 1Gastrointestinal 1Classical hematology 1

Conditions

Solid Tumors 2

Interventions

Cisplatin 147pembrolizumab 129Carboplatin 126Injections 108Pemetrexed 99Paclitaxel 97Gemcitabine 85Irinotecan 75Cyclophosphamide 72Nivolumab 71Docetaxel 68Bevacizumab 59Oxaliplatin 50Fluorouracil 50Capecitabine 48atezolizumab 46Leucovorin 42Etoposide 42tislelizumab 40toripalimab 36fludarabine 32Drug Therapy 32Ipilimumab 30Topotecan 29durvalumab 28Vincristine 27Specimen Handling 27Early Intervention, Educational 27Radiotherapy 26Interviews as Topic 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
darinaparsin × Other solid neoplasm × Clear all
NCT00509782 2012-08-01

Phase I Trial of ZIO-101 in Patients With Solid Tumors

M.D. Anderson Cancer Center

Phase 1 Completed
47 enrolled
Other solid neoplasm

Solid Tumors

NCT00591396 2012-07-19

A Phase I Trial of ZIO-101 in Solid Tumors

Alaunos Therapeutics

Phase 1 Completed
40 enrolled
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡